Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1 First-in-Human, Time Lagged, Randomised, Placebo Controlled, Double Blind, Single Ascending Dose Study of TY027 in Healthy Adult Volunteers

NCT04429529 is registered in ClinicalTrials.gov with Tychan Pte Ltd. as lead sponsor.

NCT NCT04429529
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04429529 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1 First-in-Human, Time Lagged, Randomised, Placebo Controlled, Double Blind, Single Ascending Dose Study of TY027 in Healthy Adult Volunteers
Lead sponsor
Tychan Pte Ltd.
Phase
Phase 1
Overall status
Completed
Start date
June 9, 2020
Completion date
January 20, 2021
Enrollment
32 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronavirus disease-2019 (covid-19)